Lonza
Matt Ferguson is a seasoned professional with extensive experience in pharmaceutical product development and quality management. Currently serving as the Senior Director and Head of Product Development at Lonza since March 2020, Matt oversees the design of drug products for oral and respiratory delivery, leading a team of scientists and engineers in addressing complex challenges such as bioavailability and targeted delivery. Previous roles at Catalent Pharma Solutions, including Manager of Quality and Manager of Inhalation Product Development, emphasized their leadership in quality control and regulatory compliance. With foundational experiences at GlaxoSmithKline and Cirrus Pharmaceuticals, Matt's career reflects a strong background in inhalation product formulation and quality assurance. Matt holds a B.S. in Chemistry from North Carolina State University and is currently pursuing an MBA at Oregon State University.
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.